Wrobel Anna, Russell Samantha E, Dean Olivia M, Cotton Sue, Berk Michael, Turner Alyna
IMPACT-The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Orygen, Parkville, Victoria, Australia.
BMJ Open. 2021 Apr 29;11(4):e044569. doi: 10.1136/bmjopen-2020-044569.
Despite available pharmacological and psychological treatments, remission rates for bipolar disorder remain relatively low. Current research implicates the experience of childhood trauma as a potential moderator of poor treatment outcomes among individuals with bipolar disorder. To date, the evidence reporting the influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder has not been systematically reviewed.
MEDLINE Complete, Embase, PsycINFO and the Cochrane Central Register of Controlled Trials will be searched to identify randomised and nonrandomised studies of pharmacological and/or psychological interventions for bipolar disorder, which also assessed childhood trauma. To be eligible for inclusion, studies must have been conducted with adolescents or adults (≥10 years). Data will be screened and extracted by two independent reviewers. The methodological quality of the included studies will be assessed with the Cochrane Collaboration's Risk of Bias tool and the Newcastle-Ottawa Scale. If deemed viable, a meta-analysis will be conducted using a random effects model. Heterogeneity of evidence will be estimated with the I² statistics.
This systematic review will use only previously published data. Therefore, ethical approval is not required. The results will be written in concordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines, published in peer-reviewed journals and presented at relevant conferences.
CRD42020201891.
尽管有可用的药物和心理治疗方法,但双相情感障碍的缓解率仍然相对较低。目前的研究表明,童年创伤经历可能是双相情感障碍患者治疗效果不佳的一个潜在调节因素。迄今为止,尚未对关于童年创伤对青少年和成年双相情感障碍患者药物和/或心理干预治疗效果影响的证据进行系统综述。
将检索MEDLINE Complete、Embase、PsycINFO和Cochrane对照试验中央注册库,以识别针对双相情感障碍的药物和/或心理干预的随机和非随机研究,这些研究还评估了童年创伤。要符合纳入条件,研究必须针对青少年或成年人(≥10岁)进行。数据将由两名独立的评审员进行筛选和提取。纳入研究的方法学质量将使用Cochrane协作网的偏倚风险工具和纽卡斯尔-渥太华量表进行评估。如果认为可行,将使用随机效应模型进行荟萃分析。证据的异质性将用I²统计量进行估计。
本系统综述将仅使用先前发表的数据。因此,无需伦理批准。结果将按照系统综述和荟萃分析的首选报告项目指南撰写,发表在同行评审期刊上,并在相关会议上展示。
PROSPERO注册号:CRD42020201891。